PCR技術の世界市場

PCR技術の世界市場は2030年までに140億米ドルに達する見込み

2024年に110億米ドルと推定されるPCR技術の世界市場は、2024年から2030年にかけてCAGR 4.2%で成長し、2030年には140億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるPCRソフトウェア＆サービスは、CAGR 3.9％を記録し、分析期間終了までに74億米ドルに達すると予測されます。PCR機器セグメントの成長率は、分析期間中CAGR 4.8%と推定されます。

米国市場は30億米ドルと推定、中国はCAGR7.6％で成長予測

米国のPCR技術市場は2024年に30億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに29億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と3.2%と予測されています。欧州では、ドイツがCAGR 2.4%で成長すると予測されています。

世界のPCR技術市場- 主要動向と促進要因のまとめ

技術の多様化にもかかわらず、PCR技術が分子診断における優位性を維持している理由とは？

ポリメラーゼ連鎖反応（PCR）技術は、DNAおよびRNA配列の検出における比類のない感度、特異性、汎用性により、分子診断におけるゴールドスタンダードであり続けています。等温増幅やCRISPRベースのアッセイなど、より新しい核酸増幅法が出現している一方で、PCRは感染症検査、がん診断、遺伝子スクリーニング、法医学的分析の要であり続けています。COVID-19パンデミックにおけるPCRの重要な役割は、その比類ないスケーラビリティと集中型検査室とポイントオブケアの両方への適応性を浮き彫りにしました。

リアルタイム定量PCR（qPCR）とデジタルPCR（dPCR）は、ウイルス量、遺伝子発現、希少変異検出の正確な定量化を可能にすることで、技術的展望を広げています。ゲノム検査が臨床ワークフローの主流になるにつれ、PCRシステムは自動サンプル調製、サーマルサイクリング、蛍光ベースの検出モジュールとますます統合され、エンドツーエンドの診断ソリューションを提供するようになっています。PCR装置の小型化と多重化における継続的な技術革新は、分散化された検査環境においてこの技術をより利用しやすくしています。

ポイントオブケア検査、腫瘍学、ファーマコゲノミクスはPCRの新たな需要をどのように促進しているか？

少ないサンプル量から短いターンアラウンドタイムで正確な結果を提供するPCRの能力は、分散化された患者に近い環境での使用を拡大しています。ポータブルおよびカートリッジベースのPCRプラットフォームは現在、呼吸器感染症、性感染症、および抗菌剤耐性遺伝子の迅速なスクリーニングのために、診療所、空港、および地域保健センターで展開されています。これらのシステムは中央研究所への依存を減らし、タイムリーな介入とアウトブレイク封じ込めをサポートします。

腫瘍学では、PCRはリアルタイム変異検出、遺伝子融合解析、最小残存病変（MRD）モニタリングを可能にしています。dPCRに基づくリキッドバイオプシーアッセイは、がんサーベイランスと治療反応追跡のための強力なツールとして台頭してきています。CYP450ジェノタイピングや標的治療薬のコンパニオン診断のようなファーマコゲノミクス・アプリケーションは、個別化治療レジメンをサポートするPCRパネルの採用をさらに促進しています。これらの開発により、PCRは世界的に精密医療への取り組みにおける主要なプレーヤーとして位置づけられています。

なぜ自動化、ワークフロー統合、コスト最適化がPCRプラットフォームを再定義しているのか？

ハイスループット検査と効率的なラボワークフローの推進は、完全に統合されたPCRシステムの革新を促しています。自動化されたプラットフォームは現在、単一のクローズドシステム内にサンプル溶解、核酸抽出、増幅、結果解釈を組み込んでおり、コンタミネーションリスクとマニュアルエラーを最小限に抑えています。ロボット分注システム、バーコード追跡、LIS（ラボラトリー情報システム）統合は、中量から大量生産ラボの標準機能になりつつあります。

同時に、試薬と消耗品の最適化により1検査あたりのコストが下がり、リソースに制約のある環境でもPCRを実行可能にしています。凍結乾燥試薬フォーマット、オープンアクセスキット、およびアッセイ間の試薬共有は、検査室が診断精度を維持しながらコスト圧力に対処することを可能にしています。低コストのサーモサイクラーやスマートフォンベースの蛍光リーダーの開発もまた、農村やフィールド環境におけるPCRへのアクセスを民主化しています。

PCR技術世界市場の持続的成長の原動力は？

PCR技術市場の成長は、世界の疾病負担の増加、遺伝子検査の採用拡大、臨床診断、研究、公衆衛生監視におけるアプリケーションの拡大など、いくつかの要因によって牽引されています。主要な促進要因は、PCRが幅広い病原体、遺伝子マーカー、体細胞変異を検出する汎用性があることであり、これは分野を超えた普遍的なツールとなっています。

政府の資金援助、ライフサイエンスへの民間投資、PCRベースの体外診断（IVD）キットの規制認可は、世界中でPCRインフラの展開を加速しています。一方、マイクロ流体工学、クラウドベースの結果管理、AIを活用したデータ解釈における技術的進歩は、PCRプラットフォームの使いやすさと拡張性を高めています。

世界のヘルスケアシステムは、迅速、正確、適応性の高い診断技術への依存度を高めており、PCRは今後も分子診断学の重要な柱であり続け、個別化医療、アウトブレイクへの備え、生物医学イノベーションの未来を支えます。

セグメント

製品（ソフトウェア＆サービス、装置、試薬＆消耗品）;技術（コンベンショナルPCR、リアルタイムPCR、デジタルPCR、逆転写PCR、ホットスタートPCR、マルチプレックスPCR、その他技術）;エンドユーザー（病院＆診断センター、ヘルスケア、学術＆政府機関、製薬・バイオ企業、応用産業、その他エンドユーザー）

調査対象企業の例（全48件）

• Abbott Laboratories
• Agilent Technologies Inc.
• Analytik Jena AG
• Becton, Dickinson and Company（BD）
• bioMerieux SA
• Bioneer Corporation
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Eppendorf SE
• F. Hoffmann-La Roche Ltd
• Hologic, Inc.
• Illumina, Inc.
• Merck KGaA
• Novogenia GmbH
• PerkinElmer Inc.
• Promega Corporation
• QIAGEN N.V.
• Sansure Biotech Inc.
• Siemens Healthineers
• Thermo Fisher Scientific Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global PCR Technology Market to Reach US$14.0 Billion by 2030

The global market for PCR Technology estimated at US$11.0 Billion in the year 2024, is expected to reach US$14.0 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. PCR Software & Services, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the PCR Instruments segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 7.6% CAGR

The PCR Technology market in the U.S. is estimated at US$3.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global PCR Technology Market - Key Trends & Drivers Summarized

Why Is PCR Technology Retaining Its Dominance in Molecular Diagnostics Despite Technological Diversification?

Polymerase chain reaction (PCR) technology remains the gold standard in molecular diagnostics due to its unmatched sensitivity, specificity, and versatility in detecting DNA and RNA sequences. While newer nucleic acid amplification methods such as isothermal amplification and CRISPR-based assays are emerging, PCR continues to be the cornerstone of infectious disease testing, cancer diagnostics, genetic screening, and forensic analysis. Its critical role in the COVID-19 pandemic highlighted its unmatched scalability and adaptability for both centralized laboratories and point-of-care settings.

Real-time quantitative PCR (qPCR) and digital PCR (dPCR) are expanding the technological landscape by enabling precise quantification of viral load, gene expression, and rare mutation detection. As genomic testing becomes mainstream in clinical workflows, PCR systems are increasingly integrated with automated sample preparation, thermal cycling, and fluorescence-based detection modules to provide end-to-end diagnostic solutions. The continued innovation in PCR instrument miniaturization and multiplexing is making the technology more accessible across decentralized testing environments.

How Are Point-of-Care Testing, Oncology, and Pharmacogenomics Fueling New Demand for PCR?

PCR's ability to deliver accurate results from small sample volumes within short turnaround times is expanding its use in decentralized and near-patient settings. Portable and cartridge-based PCR platforms are now being deployed in clinics, airports, and community health centers for rapid screening of respiratory infections, sexually transmitted diseases, and antimicrobial resistance genes. These systems reduce dependency on centralized labs and support timely intervention and outbreak containment.

In oncology, PCR is enabling real-time mutation detection, gene fusion analysis, and minimal residual disease (MRD) monitoring. Liquid biopsy assays based on dPCR are emerging as powerful tools for cancer surveillance and treatment response tracking. Pharmacogenomic applications, such as CYP450 genotyping and companion diagnostics for targeted therapies, are further driving the adoption of PCR panels that support personalized treatment regimens. These developments are positioning PCR as a key player in precision medicine initiatives globally.

Why Are Automation, Workflow Integration, and Cost Optimization Redefining PCR Platforms?

The push for high-throughput testing and efficient laboratory workflows is prompting innovation in fully integrated PCR systems. Automated platforms now incorporate sample lysis, nucleic acid extraction, amplification, and result interpretation within a single closed system, minimizing contamination risks and manual errors. Robotic pipetting systems, barcode tracking, and LIS (Laboratory Information System) integrations are becoming standard features in medium- to high-volume laboratories.

Simultaneously, reagent and consumable optimization is lowering the cost per test, making PCR viable even in resource-constrained settings. Lyophilized reagent formats, open-access kits, and reagent sharing across assays are enabling laboratories to manage cost pressures while maintaining diagnostic accuracy. The development of low-cost thermocyclers and smartphone-based fluorescence readers is also democratizing PCR access in rural and field settings.

What’s Driving the Sustained Growth of the Global PCR Technology Market?

The growth in the PCR technology market is driven by several factors including rising global disease burden, increasing adoption of genetic testing, and expanding applications in clinical diagnostics, research, and public health surveillance. A key growth driver is the versatility of PCR in detecting a wide spectrum of pathogens, genetic markers, and somatic mutations-making it a universal tool across disciplines.

Government funding, private investment in life sciences, and regulatory approval of PCR-based in vitro diagnostic (IVD) kits are accelerating the deployment of PCR infrastructure worldwide. Meanwhile, technological advancements in microfluidics, cloud-based result management, and AI-powered data interpretation are enhancing the usability and scalability of PCR platforms.

With the global healthcare system increasingly relying on rapid, precise, and adaptable diagnostic technologies, PCR will remain a vital pillar of molecular diagnostics-powering the future of personalized medicine, outbreak preparedness, and biomedical innovation.

SCOPE OF STUDY:

The report analyzes the PCR Technology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Software & Services, Instruments, Reagents & Consumables); Technology (Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR, Multiplex PCR, Other Technologies); End-Use (Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• Abbott Laboratories
• Agilent Technologies Inc.
• Analytik Jena AG
• Becton, Dickinson and Company (BD)
• bioMerieux SA
• Bioneer Corporation
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Eppendorf SE
• F. Hoffmann-La Roche Ltd
• Hologic, Inc.
• Illumina, Inc.
• Merck KGaA
• Novogenia GmbH
• PerkinElmer Inc.
• Promega Corporation
• QIAGEN N.V.
• Sansure Biotech Inc.
• Siemens Healthineers
• Thermo Fisher Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • PCR Technology - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Molecular Diagnostics Drives Widespread Adoption of PCR Technology in Clinical Labs
  • Expansion of Infectious Disease Testing Throws the Spotlight on Real-Time PCR for Rapid Pathogen Detection
  • OEM Innovation in Digital PCR and qPCR Enhances Sensitivity and Quantitative Accuracy in Low-Abundance Samples
  • Growth in Genomic and Cancer Research Accelerates Use of PCR in Gene Expression and Mutation Analysis
  • OEM Development of Portable and Point-of-Care PCR Devices Expands Use in Remote and Resource-Limited Settings
  • Increased Investment in Biothreat Detection and Pandemic Preparedness Spurs PCR Capacity Expansion
  • OEM Collaboration With IVD Manufacturers Strengthens Application-Specific Kit Development
  • Integration of PCR With Microfluidics and Lab-on-Chip Platforms Drives Miniaturization and Multiplexing
  • OEM Advances in Fast-Cycling and One-Step PCR Kits Shorten Diagnostic Turnaround Times
  • Expansion of Agricultural, Food Safety, and Veterinary PCR Testing Broadens Market Scope
  • OEM Investment in Enzyme and Master Mix Optimization Improves Assay Robustness Across Matrices
  • Rising Demand for Personalized Medicine and Companion Diagnostics Spurs Precision PCR Applications
  • OEM Participation in Global Health Surveillance Programs Supports Mass PCR Testing Infrastructure
  • Growth in Environmental Monitoring and Water Quality Testing Enhances Demand for Pathogen-Specific PCR Assays
  • OEM Emphasis on Automation and High-Throughput PCR Platforms Supports Genomic Scale Screening
  • Increasing Integration of AI for PCR Data Interpretation Accelerates Diagnostic Insights
  • OEM Development of Lyophilized and Room-Temperature Stable Reagents Improves Logistics Efficiency
  • Rising Preference for CE-IVD and FDA-Approved PCR Kits Enhances Regulatory Compliant Adoption
  • OEM Advances in Cloud-Connected PCR Systems Support Remote Access and Workflow Management
  • Global Standardization and Pandemic Legacy Infrastructure Sustain Long-Term PCR Market Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World PCR Technology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Conventional PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Conventional PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Conventional PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Real-Time PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Real-Time PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Real-Time PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Digital PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Digital PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Digital PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Reverse Transcription PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Reverse Transcription PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Reverse Transcription PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hot-Start PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hot-Start PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Hot-Start PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Multiplex PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Multiplex PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Multiplex PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Academic & Government Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Academic & Government Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Academic & Government Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Applied Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Applied Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Applied Industries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 53: USA Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 62: Canada Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 80: China Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 89: Europe Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for PCR Technology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 110: Germany Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 119: Italy Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 122: Italy Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 125: Italy Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 128: UK Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 131: UK Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: UK Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: UK 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 134: UK Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: UK Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: UK 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 137: Spain Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 140: Spain Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Spain Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Spain 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 143: Spain Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Spain Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Spain 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 146: Russia Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 149: Russia Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Russia Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Russia 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 152: Russia Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Russia Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Russia 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Europe Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Rest of Europe 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Rest of Europe Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Rest of Europe 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for PCR Technology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Asia-Pacific Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Asia-Pacific 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Asia-Pacific Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Asia-Pacific 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 176: Australia Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 179: Australia Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Australia Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Australia 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 182: Australia Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Australia Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Australia 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 185: India Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 188: India Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: India Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: India 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 191: India Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: India Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: India 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 197: South Korea Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: South Korea Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: South Korea 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 200: South Korea Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: South Korea Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: South Korea 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Asia-Pacific Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 209: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Asia-Pacific Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Rest of Asia-Pacific 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for PCR Technology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 218: Latin America Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Latin America Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Latin America 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 221: Latin America Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Latin America Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Latin America 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 227: Argentina Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Argentina Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Argentina 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 230: Argentina Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Argentina Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Argentina 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 236: Brazil Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Brazil Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Brazil 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 239: Brazil Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Brazil Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Brazil 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 245: Mexico Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Mexico Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Mexico 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 248: Mexico Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Mexico Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Mexico 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Latin America Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Latin America 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 257: Rest of Latin America Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Latin America Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Rest of Latin America 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for PCR Technology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 266: Middle East Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Middle East Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Middle East 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 269: Middle East Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Middle East Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Middle East 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 272: Iran Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 275: Iran Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Iran Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Iran 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 278: Iran Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Iran Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Iran 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 281: Israel Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 284: Israel Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Israel Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Israel 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 287: Israel Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Israel Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Israel 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Saudi Arabia Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Saudi Arabia 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 296: Saudi Arabia Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Saudi Arabia Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Saudi Arabia 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 299: UAE Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 302: UAE Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: UAE Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: UAE 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 305: UAE Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: UAE Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: UAE 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Middle East Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Middle East 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Middle East Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Middle East Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Middle East 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • PCR Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 317: Africa Recent Past, Current & Future Analysis for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for PCR Technology by Product - Software & Services, Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for PCR Technology by Product - Percentage Breakdown of Value Sales for Software & Services, Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
  • TABLE 320: Africa Recent Past, Current & Future Analysis for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Africa Historic Review for PCR Technology by Technology - Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Africa 15-Year Perspective for PCR Technology by Technology - Percentage Breakdown of Value Sales for Other Technologies, Conventional PCR, Real-Time PCR, Digital PCR, Reverse Transcription PCR, Hot-Start PCR and Multiplex PCR for the Years 2015, 2025 & 2030
  • TABLE 323: Africa Recent Past, Current & Future Analysis for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Africa Historic Review for PCR Technology by End-Use - Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Africa 15-Year Perspective for PCR Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Healthcare, Academic & Government Organizations, Pharma-Biotech Companies, Applied Industries and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION